onconox.com onconox.com

onconox.com

Home

OncoNOx develops innovative, proprietary treatments for human diseases. Using our unique medicinal chemistry approach, we generate. Or transform already marketed compounds into powerful drugs, which potently inhibit disease pathogenetic pathways in validated animal models resembling human diseases. Read more here -. Proof-of-concept demonstrated in animal models of human disease. Strong scientific team with ties to top universities. Highly experienced management team.

http://www.onconox.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR ONCONOX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 13 reviews
5 star
7
4 star
3
3 star
2
2 star
0
1 star
1

Hey there! Start your review of onconox.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.4 seconds

FAVICON PREVIEW

  • onconox.com

    16x16

  • onconox.com

    32x32

  • onconox.com

    64x64

  • onconox.com

    128x128

  • onconox.com

    160x160

  • onconox.com

    192x192

CONTACTS AT ONCONOX.COM

OncoNox

Mai-Britt Zocca

Ole Ma●●●●●●svej 3

Koeb●●●●vn N , 2200

DK

View this contact

One.com

Host Master

Kalveb●●●●●●gge 24

Cope●●●●en V , 1560

DK

45.4●●●●7100
45.7●●●●5872
ho●●●●●●●●@one.com

View this contact

One.com

Host Master

Kalveb●●●●●●gge 24

Cope●●●●en V , 1560

DK

45.4●●●●7100
45.7●●●●5872
ho●●●●●●●●@one.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2011 May 16
UPDATED
2014 June 20
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 14

    YEARS

  • 0

    MONTHS

  • 27

    DAYS

NAME SERVERS

1
ns01.one.com
2
ns02.one.com

REGISTRAR

ASCIO TECHNOLOGIES, INC.

ASCIO TECHNOLOGIES, INC.

WHOIS : whois.ascio.com

REFERRED : http://www.ascio.com

CONTENT

SCORE

6.2

PAGE TITLE
Home | onconox.com Reviews
<META>
DESCRIPTION
OncoNOx develops innovative, proprietary treatments for human diseases. Using our unique medicinal chemistry approach, we generate. Or transform already marketed compounds into powerful drugs, which potently inhibit disease pathogenetic pathways in validated animal models resembling human diseases. Read more here -. Proof-of-concept demonstrated in animal models of human disease. Strong scientific team with ties to top universities. Highly experienced management team.
<META>
KEYWORDS
1 news
2 transforming patients' lives
3 onconox aps
4 de novo
5 about onconox
6 coupons
7 reviews
8 scam
9 fraud
10 hoax
CONTENT
Page content here
KEYWORDS ON
PAGE
news,transforming patients' lives,onconox aps,de novo,about onconox
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Home | onconox.com Reviews

https://onconox.com

OncoNOx develops innovative, proprietary treatments for human diseases. Using our unique medicinal chemistry approach, we generate. Or transform already marketed compounds into powerful drugs, which potently inhibit disease pathogenetic pathways in validated animal models resembling human diseases. Read more here -. Proof-of-concept demonstrated in animal models of human disease. Strong scientific team with ties to top universities. Highly experienced management team.

INTERNAL PAGES

onconox.com onconox.com
1

OncoNOx

http://www.onconox.com/index.htm

Lead compounds are powerful anticancer drugs. Proof-of-concept demonstrated in mouse models of human cancer. Synergy in vitro with commonly used chemotherapeutic agents. Strong scientific team with ties to top universities. Highly experienced management team. OncoNOx develops novel, proprietary anti-cancer agents. Using our unique medicinal chemistry approach, we transform already marketed compounds into powerful cytotoxic drugs, which potently inhibit cancer in validated animal models.

2

OncoNOx

http://www.onconox.com/news.htm

July 2014 OncoNOx completes license. OncoNOx completes license agreement. Copenhagen and Monthey, July, 2014. OncoNOx (Copenhagen, Denmark) grants Inflamalps SA (Monthey, Switzerland) an exclusive option to license and develop its front-runner drug candidate OX1001 for the treatment of inflammatory diseases. We are pleased to sign this agreement with the highly qualified management team of Inflamalps , said Mai-Britt Zocca, Chief Executive Officer, OncoNox. We are very confident that this newly funde...

3

OncoNOx

http://www.onconox.com/products.htm

OncoNOx is a BioPharmaceutical Company focused on designing novel NO-containing/releasing small molecules based on clinically validated chemical scaffolds. OncoNOx’s technology transforms marketed drugs into novel, proprietary molecules with potent anti-cancer properties and an improved therapeutic profile by covalent attachment of a nitric oxide (NO) moiety to the chemical structure. The lead projects; OX1001. Have both been shown to be potent anti-cancer compounds. Ole Maaløes Vej 3 -.

4

OncoNOx

http://www.onconox.com/about.htm

OncoNOx is pharmaceutical company focused on the devlopment of innovative treatments by transforming already marketed drugs into novel, proprietary molecules with anti-cancer and/or anti-inflammatory properties and improved therapeutic profile. OncoNOx was founded in 2011 by a highly experienced group of scientists and biotech executives (see Founders. And has strong ties to research groups in Italy, the US, and Serbia. Ole Maaløes Vej 3 -.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

OTHER SITES

onconord.org onconord.org

Accueil - Réseau de cancérologie Onconord - Ile de France

Les établissements du réseau. Le territoire d intervention du réseau. Nous faire un don, c est soutenir Onconord dans l ensemble de ses actions. Bienvenue sur le site Internet du Réseau Onconord. Durant les diverses étapes de la maladie, il peut être soigné dans différents lieux. Il est très important que les professionnels communiquent au mieux pour travailler dans le même sens, dans l’intérêt du patient. Les établissements et le territoire dintervention du réseau.

onconostica.com onconostica.com

onconostica.com -&nbsponconostica Resources and Information.

onconotes.org onconotes.org

OncoNotes [Article name]

onconova.com onconova.com

Onconova Therapeutics, Inc. - A Phase 3 stage biopharmaceutical company

INVESTORS & MEDIA. Corporate Events & Presentations. Annual Reports and Proxies. Lead Candidate, Rigosertib, in Phase 3 Trials for Myelodysplastic Syndromes (MDS). A Blood Cancer Resulting From Bone Marrow Failure. Learn more about MDS. More Than 10,000 Patients Currently Have High-risk MDS; A Large Unmet Medical Need. Late-stage Trials Include Stand-alone And Combination Therapies. Learn more about our Clinical Trials. Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused ...

onconox.com onconox.com

Home

OncoNOx develops innovative, proprietary treatments for human diseases. Using our unique medicinal chemistry approach, we generate. Or transform already marketed compounds into powerful drugs, which potently inhibit disease pathogenetic pathways in validated animal models resembling human diseases. Read more here -. Proof-of-concept demonstrated in animal models of human disease. Strong scientific team with ties to top universities. Highly experienced management team.

onconsciousness.com onconsciousness.com

On Consciousness – On the Nature of Our Decisions and Our Psyche

On the Nature of Our Decisions and Our Psyche. March 16, 2016. March 16, 2016. My first year of graduate school a friend told me I reminded her of Pacey on Dawson’s Creek. She told me I was a ‘pretty boy’ and asked me rhetorically, “shouldn’t you be working in finance? 8221; I told her she sounded like my father. She apologized. The choice, to do the work that seeks equality and …. On Identity and Collective Trauma. March 2, 2016. March 2, 2016. What does it mean to be white in this country? Oh music&#46...

onconsensus.com onconsensus.com

On Consensus | This WordPress.com site is the bee's knees

This WordPress.com site is the bee's knees. Apologies, but no results were found. Perhaps searching will help find a related post. The Twenty Twelve Theme. Blog at WordPress.com. Create a free website or blog at WordPress.com. The Twenty Twelve Theme. Follow “On Consensus”. Get every new post delivered to your Inbox. Build a website with WordPress.com. Add your thoughts here. (optional).

onconsignment.com onconsignment.com

Price Request - BuyDomains

Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.

onconsignment.net onconsignment.net

OnConsignment | Online Shopping Store

Welcome to our online store. We have many products that are competitively priced and adding new products all the time. We have cameras, laptops, tablets, cellphones and much more. If you don’t find what you are looking for, give us a shout, maybe we can get it for you and charge you a lot less. Camera Accessories,Camera Accessories. Mobile and Tablet Accessories. Smart Watches and Accessories.

onconstellations.com onconstellations.com

On Constellations: Delving Deeper into Constellation Work

Delving Deeper into Constellation Work. Dynamic Constellations FREE Demo Jan 2014. December 31, 2013. Dynamic Constellations FREE Demo January 2014 Unfamiliar with the Constellation Method? Experience this powerful set of techniques of vibration pattern transformation to resolve relationship, finance, career, family and health issues for FREE. If you are in the Chicago area, join us for this free Dynamic Constellations Demo offered Saturday, January 18, 2014 from 1 3pm […]. Full Story ». Page 1 of 10.